Aberrant localization of signaling proteins in skin cancer: Implications for treatment

Thomas R Holmes1, Shravya Dindu1, Laura A Hansen1

  • 1Department of Biomedical Sciences, Creighton University, Omaha, Nebraska.

Insights

Aberrant protein localization in cancer cells, particularly skin cancer, can drive tumor growth and resistance to therapy. Understanding these shifts offers new therapeutic targets for improved patient outcomes.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Aberrant subcellular localization of signaling proteins confers cancer cell advantages like apoptosis resistance, invasiveness, and proliferation.
  • Nuclear to cytoplasmic shifts in tumor-promoting proteins correlate with poorer patient outcomes.
  • Dysregulated protein localization is a common hallmark of cancer, impacting key cellular processes.

Purpose of the Study:

  • To review the significance of dysregulated protein localization in cancer.
  • To focus on the role of altered protein localization in skin cancer.
  • To highlight the potential of targeting aberrant localization for cancer therapeutics.

Main Methods:

  • Literature review of studies on protein localization and cancer.
  • Analysis of signaling pathways affected by protein mislocalization.
  • Examination of therapeutic strategies targeting protein localization.

Main Results:

  • Altered localization of cell cycle and cell death regulators is frequent in cancer.
  • Aberrant localization can result in acquired prosurvival functions for cancer cells.
  • Specific protein localization shifts are critical in skin cancer progression.

Conclusions:

  • Dysregulated protein localization is a critical factor in cancer development and progression.
  • Targeting aberrant subcellular protein localization presents a promising therapeutic avenue.
  • Further research into protein localization mechanisms can yield novel anti-cancer drugs.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.8K
Nuclear Localization Signals and Import01:46

Nuclear Localization Signals and Import

Proteins targeted to the nucleus carry short stretches of amino acid sequences called the nuclear localization signal or NLS. Classical nuclear localization signals are of two types: monopartite and bipartite NLS. Monopartite classical NLS (cNLS) consists of a single cluster of 4-8 amino acids. Bipartite cNLS consists of two clusters of  2-3 amino acids and a 9-12 residue long proline-rich linker bridging the two clusters. Signal clusters are rich in positively charged amino acids such as...
7.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
Paracrine Signaling01:21

Paracrine Signaling

Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
59.5K
Yeast Signaling01:28

Yeast Signaling

Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
17.2K